Inhibition of SPARC expression suppresses the tumorigenicity of human melanoma Cells in nude mice (pages 171–176).
This is a preview of subscription content, log in via an institution to check access.
References
Ledda, M.F. et al. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nature Med. 3, 171–176 (1997).
Lane, T.F., & Sage, E.H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8, 163–173 (1994).
Porter, P.L., Sage, E.H., Lane, T.F., Funk, S.E. & Gown, A.M. Distribution of SPARC in normal and neoplastic human tissue. J. Histochem. Cytochem 43, 791–800 (1995).
Sage, E.H. & Bornstein, P., Extracellular proteins that modulate cell-matrix interactions: SPARC, tenascin, and thrombospondin. J. Biol. Chem. 266, 14831–14834 (1991).
Bornstein, P. Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1. J. Cell Biol. 130, 503–506 (1995).
Hohenester, E. et al. Structure of a novel extracellular Ca2+-binding module in BM-40. Nature Struct. Biol. 3, 67–73 (1996).
Sage, E.H. Angiogenesis inhibition in the context of endothelial cell biology. Adv. Oncol. 12, 17–29 (1996).
Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353–364 (1996).
Roberts, D.D. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J. 10, 1183–1191 (1996).
Pepper, M.S., Montesano, R., Mandriota, S.J., Orci, L. & Vassalli, J.D. Angiogenesis: A paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49, 138–162 (1996).
Huttenlocher, A., Sandborg, R.R. & Horwitz, A.F., Adhesion in cell migration. Curr. Opin. Cell Biol. 7, 697–706 (1995).
Ruoslahti, E. & Öbrink, B., Common principles in cell adhesion. Exp. Cell Res. 227, 1–11 (1996).
Brooks, P.C. et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αv,β3 . Cell 85, 683–693 (1996).
Iruela-Arispe, M.L., Vernon, R.B., Wu, H., Jaenisch, R. & Sage, E.H. Type I collagen-deficient mov 13 mice do not retain SPARC in the extracellular matrix: Implications for fibroblast function. Dev. Dyn. 207, 171–183 (1996).
Schwartz, M.A., Schaller, M.D. & Ginsberg, M.H., Emerging paradigms of signal transduction. Annu. Rev. Cell Dev. Biol. 11, 549–599 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Helene Sage, E. Terms of attachment: SPARC and tumorigenesis. Nat Med 3, 144–146 (1997). https://doi.org/10.1038/nm0297-144
Issue Date:
DOI: https://doi.org/10.1038/nm0297-144
- Springer Nature America, Inc.
This article is cited by
-
A Novel S100A8/A9 Induced Fingerprint of Mesenchymal Stem Cells associated with Enhanced Wound Healing
Scientific Reports (2018)
-
Association of SPARC gene polymorphisms rs3210714 and rs7719521 with VEGF expression and utility of Nottingham Prognostic Index scoring in breast cancer in a sample of Egyptian women
Molecular Biology Reports (2018)
-
The role of the extracellular matrix in primary myelofibrosis
Blood Cancer Journal (2017)
-
In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions
BMC Genomics (2007)
-
Aberrant methylation of SPARC in human lung cancers
British Journal of Cancer (2005)